Note: Lancet requires free registration prior to providing content. “Oral sapacitabine for the treatment of acute myeloid leukaemia in elderly patients: a randomised phase 2 study,” by Hagop Kantarjian, Stefan Faderl, Guillermo Garcia-Manero, Selina Luger, Parameswaran Venugopal, Lori Maness, Meir Wetzler, Steven Coutre, Wendy Stock, David Claxton, Stuart L Goldberg, Martha Arellano, Stephen A Strickland, Karen Seiter, Gary Schiller, Elias Jabbour, Judy Chiao, and William Plunkett (Vol. 13, No. 11, November 2012, p. 1096-1104).
www.thelancet.com/journals/lanonc/article/PIIS1470-2045%2812%2970436-9/abstract
